Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk

por Luo, C., Qin, S.-X., Wang, Q.-Y., Li, Y.-F., Qu, X.-L., Yue, C., Hu, L., Sheng, Z.-F., Wang, X.-B., Wan, X.-M.
Publicado 2022